Successful laparoscopic trans-peritoneal repair of an incisional inguinal hernia, resulting from deep lymph node dissection for melanoma: A case report

[1]  L. Cappabianca,et al.  Advanced Merkel cell carcinoma of the lower extremity treated with surgery and isolated pelvic and limb perfusion using Melphalan: A case of unexpected long-term survival , 2019, International journal of surgery case reports.

[2]  Priya Ranganathan,et al.  The SCARE 2018 statement: Updating consensus Surgical CAse REport (SCARE) guidelines. , 2018, International journal of surgery.

[3]  S. Federico,et al.  Laparoscopic treatment of obstructed internal supravesical hernia: A cases series and rewiev of the literature , 2018, Annals of medicine and surgery.

[4]  J. Bonenkamp,et al.  Optimal extent of completion lymphadenectomy for patients with melanoma and a positive sentinel node in the groin , 2017, The British journal of surgery.

[5]  K. Peris,et al.  Heterogeneity of BRAF, NRAS, and TERT Promoter Mutational Status in Multiple Melanomas and Association with MC1R Genotype: Findings from Molecular and Immunohistochemical Analysis. , 2018, The Journal of molecular diagnostics : JMD.

[6]  M. Valenti,et al.  Does Locoregional Chemotherapy Still Matter in the Treatment of Advanced Pelvic Melanoma? , 2017, International journal of molecular sciences.

[7]  M. Valenti,et al.  Surgical versus percutaneous isolated pelvic perfusion (IPP) for advanced melanoma: comparison in terms of melphalan pharmacokinetic pelvic bio-availability , 2017, BMC Research Notes.

[8]  M. Valenti,et al.  Melphalan hypoxic perfusion with hemofiltration for melanoma locoregional metastases in the pelvis. , 2017, The Journal of surgical research.

[9]  A. Gesierich,et al.  Completion Dissection or Observation for Sentinel‐Node Metastasis in Melanoma , 2017, The New England journal of medicine.

[10]  M. Valenti,et al.  MGMT methylation correlates with melphalan pelvic perfusion survival in stage III melanoma patients: a pilot study , 2017, Melanoma research.

[11]  H. Nelson,et al.  Safety and Feasibility of Minimally Invasive Inguinal Lymph Node Dissection in Patients With Melanoma (SAFE-MILND): Report of a Prospective Multi-institutional Trial , 2017, Annals of surgery.

[12]  Lesly A. Dossett,et al.  Robotic-Assisted Transperitoneal Pelvic Lymphadenectomy for Metastatic Melanoma: Early Outcomes Compared with Open Pelvic Lymphadenectomy. , 2016, Journal of the American College of Surgeons.

[13]  E. Bastiaannet,et al.  Therapeutic groin dissection for melanoma: risk factors for short term morbidity. , 2009, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[14]  H. Hoekstra,et al.  Morbidity after inguinal sentinel lymph node biopsy and completion lymph node dissection in patients with cutaneous melanoma. , 2006, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[15]  M. Morgan,et al.  Saphenous vein sparing during inguinal lymphadenectomy to reduce morbidity in patients with vulvar carcinoma. , 2006, Gynecologic oncology.

[16]  B. Chauffert,et al.  Preventing Lymphedema and Morbidity With an Omentum Flap After Ilioinguinal Lymph Node Dissection , 2005, Annals of Surgical Oncology.

[17]  S. Ariyan,et al.  Preservation of muscle fascia to decrease lymphedema after complete axillary and ilioinguinofemoral lymphadenectomy for melanoma. , 2002, Journal of the American College of Surgeons.

[18]  G. Zografos,et al.  Repair after radical groin dissection , 1999, Journal of surgical oncology.

[19]  C. Karakousis.  Therapeutic node dissections in malignant melanoma , 1998, Annals of surgical oncology.

[20]  C. Karakousis.  Therapeutic node dissections in malignant melanoma. , 1998, Seminars in surgical oncology.

[21]  H. Hoekstra,et al.  Groin dissection in the treatment of lower-extremity melanoma. Short-term and long-term morbidity. , 1992, Archives of surgery.